CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale President & GM China sold 4,000 shares at $300.00 ($1,200,000)
- 4 Open-market sale CFO & Chief Strategy Officer sold 14,000 shares at an average $299.60 ($4,194,413)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $280.38 ($420,568)
- 4 Open-market sale Chief Executive Officer sold 54,303 shares at an average $280.39 ($15,226,093)
- 4 Open-market sale Director sold 5,000 shares at an average $280.42 ($1,402,116)
- 4 Open-market sale President & GM China sold 4,000 shares at $280.35 ($1,121,406)
- 4 Open-market sale Director sold 5,000 shares at an average $260.27 ($1,301,356)
- 4 Open-market sale President & GM China sold 4,000 shares at an average $260.33 ($1,041,327)
- 4 Open-market sale Chief Executive Officer sold 81,228 shares at an average $253.46 ($20,587,969)
- 4 Open-market sale CFO & Chief Strategy Officer sold 14,000 shares at an average $250.27 ($3,503,764)
- 4 Open-market sale CMO, Hematology sold 3,128 shares at an average $233.07 ($729,045)
- 4 Open-market sale Chief Executive Officer sold 61,042 shares at an average $233.21 ($14,235,597)
- 4 Open-market sale CMO, Hematology sold 3,000 shares at an average $242.21 ($726,626)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award 10% owner acquired 59,390 shares (grant or award)
- 4 Grant or award 10% owner acquired 123,566 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 92,177 shares at an average $237.06 ($21,851,789)
- 4 Grant or award 10% owner acquired 168,352 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 42,968 shares at an average $212.71 ($9,139,562)
Page 18 of 29 · 580 filings